Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

The Effectiveness of Two Different Interventions on Hip Adduction Strength in Junior Floorball Players

16 settembre 2026 aggiornato da: Kajsa Gilenstam, Umeå University

The Effectiveness of Two Different Interventions on Hip Adduction Strength in Junior Floorball Players - A Randomized Controlled Trial

Study type The present study is a two- armed randomized controlled trial. Study setting and participants 50 floorball players in high-school level will be invited to participate. An a priori power calculation indicated that 40 participants are required to detect an effect size of 0,3, with a significance level of 0.05 and a statistical power of 80%.

Recruitment and study procedure The recruitment will be performed in two steps; (1) The project will be presented to responsible floorball coaches at one high-school with the aim to get consent to contact the players in their floorball group. (2) The Research Group will visit the players to ask for individual consent.

Baseline assessment Three assessments will be performed: (a) questionnaire including demographic data, injury history, history of adductor strength training and information dominant leg, history of lower limb and lower back problems and previous experience of groin specific strength training. (b) eccentric hip adductor strength measured with a handheld dynamometer (c) isometric hip adductor and abductor strength measured with the ForceFrame Strength System (VALD).

Randomization, stratification and statistical analysis Randomization will follow an individual-randomization procedure. Randomization will take place after completion of baseline strength measurements. Allocation followed a 1:1 ratio, where the two intervention groups are equal in size. All stratification follows the allocation described under "Randomization" above.

The following variables will be stratified: Sex, and eccentric hip adductor strength (measured with a handheld dynamometer) at baseline. Analyses will follow the intention-to-treat principle using mixed-effects models.

Intervention

The intervention will consist of two parallel groups:

  • Progressive training program using the Copenhagen Adductor Exercise (CAE).
  • Progressive training program using the Adductor Slide (AS). The interventions followed a progressive protocol. The exercise was incorporated into the participants' regular training and took approximately 10 minutes on the days the intervention was performed. The intervention protocol for both groups followed an 8-week progressive loading structure with gradual increases in training volume over time. During week 1, participants completed 2 sessions per week, performing 2 sets of 6 repetitions per side. In weeks 2 and 3, the number of repetitions was increased to 8 and 10 per side, respectively, while maintaining the same weekly frequency and number of sets. In week 4, the number of sets was increased from 2 to 3, while repetitions remained at 10 per side. During weeks 5 and 6, repetitions were further increased to 12 per side, followed by 15 repetitions per side during weeks 7 and 8. Overall, the protocol progressively increased training load by manipulating repetitions first, then sets, and finally maintaining a higher training volume in the final phase.

For both interventions, each repetition was performed with a 3-second eccentric phase and a 3-second concentric phase.

Implementation and adherence The intervention was supervised by the research group. Attendance was recorded at each intervention session.

Follow-up assessment Three assessments were performed: (a) questionnaire assessing how the players experienced the intervention, if any adverse events occured, their motivation to perform the intervention and if they experienced DOMS (delayed onset muscle soreness) during the intervention (b) eccentric hip adductor strength measured with a handheld dynamometer (c) isometric hip adductor and abductor strength measured with the ForceFrame Strength System (VALD).

Outcome variables and analyses. Between-group effects will be calculated. Main outcome variables will be;

  • Eccentric hip adductor strength (measured with handheld dynamometer). The unit used will be Nm/kg.
  • Isometric hip adductor and abductor strength (measured with the ForceFrame Strength System, VALD). The unit used will be Nm/kg.
  • Ratio between isometric hip adductor and isometric hip abductor strength (measured with the ForceFrame Strength System, VALD). Percentage (i.e a measure of the strength balance between the hip adductors and abductors. Lower values indicate relatively weaker adductors compared with abductors) will be calculated to express this ratio. Potential confounders that will be analyzed as interactions will include;
  • Attendance to the intervention
  • Motivation to perform the intervention
  • Experienced DOMS
  • Contamination (i.e if the participant performed hip adductor specific training outside the intervention).

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Effettivo)

49

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Västerbotten County
      • Umeå, Västerbotten County, Svezia, 90187
        • Umeå Energi Arena

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • Floorball players between 16-20 years old
  • Not actively using any of the interventions in their daily training

Exclusion Criteria:

  • Pain or injury to the lower extremities or lower back that hinders the person from performing the assigned intervention

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Copenhagen Adductor Exercise
The Copenhagen Adduction exercise protocol followed an 8-week progressive loading structure with gradual increases in training volume over time. During week 1, participants completed 2 sessions per week, performing 2 sets of 6 repetitions per side. In weeks 2 and 3, the number of repetitions was increased to 8 and 10 per side, respectively, while maintaining the same weekly frequency and number of sets. In week 4, the number of sets was increased from 2 to 3, while repetitions remained at 10 per side. During weeks 5 and 6, repetitions were further increased to 12 per side, followed by 15 repetitions per side during weeks 7 and 8. Overall, the protocol progressively increased training load by manipulating repetitions first, then sets, and finally maintaining a higher training volume in the final phase. Each repetition is performed with a 3-second eccentric phase and a 3-second concentric phase.
The Copenhagen Adductor Exercise is performed with a partner and primarily targets the hip adductor muscles. The athlete begins in a side plank position with the lower forearm placed directly under the shoulder and the body held in a straight line. A partner stands beside the athlete and supports the upper leg by holding the ankle and, if needed, the knee. The lower leg remains free beneath the body. From the starting position, the athlete lifts the body upward by pressing the supported upper leg down into the partner's hands while simultaneously raising the lower leg to meet the upper leg. The body should remain straight and stable throughout the movement, with the hips kept elevated and aligned. The athlete then slowly lowers the lower leg back to the starting position in a controlled manner while maintaining trunk stability. After completing the prescribed repetitions on one side, the exercise is repeated on the opposite side.
Altri nomi:
  • CAE
Comparatore attivo: Adductor Slide
The Adductor Slide exercise protocol followed an 8-week progressive loading structure with gradual increases in training volume over time. During week 1, participants completed 2 sessions per week, performing 2 sets of 6 repetitions per side. In weeks 2 and 3, the number of repetitions was increased to 8 and 10 per side, respectively, while maintaining the same weekly frequency and number of sets. In week 4, the number of sets was increased from 2 to 3, while repetitions remained at 10 per side. During weeks 5 and 6, repetitions were further increased to 12 per side, followed by 15 repetitions per side during weeks 7 and 8. Overall, the protocol progressively increased training load by manipulating repetitions first, then sets, and finally maintaining a higher training volume in the final phase.
The Adductor Slide is performed in standing and targets the hip adductors while also challenging balance and trunk control. The athlete stands with one foot on a sliding surface and the other firmly planted on the floor. A resistance band is placed around the ankle of the sliding leg and positioned to pull the leg laterally away from the body. The athlete slowly slides the leg out to the side while bending the stance leg into a controlled side-lunge position, keeping the trunk upright and pelvis stable. The sliding leg is then actively pulled back to the starting position against the resistance of the band using the hip adductor muscles. The movement should be slow and controlled. After completing the prescribed repetitions, the exercise is repeated on the opposite side. Each repetition is performed with a 3-second eccentric phase and a 3-second concentric phase.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Changes in eccentric adduction strength after 8 week training period
Lasso di tempo: Measured at baseline (pre intervention) and directly after the intervention (post intervention). Post intervention = Intervention ends on a Friday, post-intervention testing will be performed during the upcoming 14 days.
Eccentric adduction strength measured with a handheld dynamometer
Measured at baseline (pre intervention) and directly after the intervention (post intervention). Post intervention = Intervention ends on a Friday, post-intervention testing will be performed during the upcoming 14 days.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Changes in isometric adduction strength and abduction strength after 8 week training period
Lasso di tempo: Pre and post intervention. Pre Intervention = Maximum 14 days before the intervention starts. Post intervention = Intervention ends on a Friday, post-intervention testing will be performed during the upcoming 14 days.
Isometric adductor strength and abductor strength measured with a stationary strength testing system (VALD ForceFrame)
Pre and post intervention. Pre Intervention = Maximum 14 days before the intervention starts. Post intervention = Intervention ends on a Friday, post-intervention testing will be performed during the upcoming 14 days.
Changes in ratio between isometric adduction strength and abduction strength after 8 week training period
Lasso di tempo: Measured at baseline (pre intervention) and directly after the intervention (post intervention). Post intervention = Intervention ends on a Friday, post-intervention testing will be performed during the upcoming 14 days.
Ratio between isometric adduction strength and abduction strength measured with a stationary strength testing system (VALD ForceFrame)
Measured at baseline (pre intervention) and directly after the intervention (post intervention). Post intervention = Intervention ends on a Friday, post-intervention testing will be performed during the upcoming 14 days.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Apostolos Theos, PhD, Umeå University
  • Investigatore principale: Kajsa Gilenstam, PhD, Umeå University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

17 gennaio 2025

Completamento primario (Effettivo)

1 giugno 2026

Completamento dello studio (Effettivo)

1 giugno 2026

Date di iscrizione allo studio

Primo inviato

1 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

16 settembre 2026

Primo Inserito (Effettivo)

17 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 settembre 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Dnr 2024-07167-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

All researchers that will be working with this data are stated in this registration

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi